In fact, similarly to other metabolic myopathies, the decline of specific hormones, including IGF-1, occurring in OP might downregulate IGF-1/PI3K/Akt activity, leading to muscle atrophy. This evidence concerns the gene IGF1 and metabolic myopathy.